Skip to main content
ANIP logo

ANI Pharmaceuticals, Inc.

ANIPNASDAQHealthcareDrug Manufacturers - Specialty & Generic

$72.60Today:- (-)1Y −22.29%

As of Oct 26, 2026 close

Market cap
$1.59B
P/E (TTM)
15.03
Forward P/E
-
Dividend yield
-
52-week range
$69.58$97.00
Volume (live)
-
Avg. volume (3M)
397.70K

ANI Pharmaceuticals (ANIP) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), ANI Pharmaceuticals had a P/E ratio of 23.50, return on equity of 16.2% (up from -4.2%), debt-to-equity of 1.16 (down from 1.46) and a current ratio of 2.71 (down from 2.72). A current ratio of 2.71 means current assets exceed current liabilities.

ANI Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income StatementBalance SheetCash FlowRatios
Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio23.50-68.00---
Forward P/E10.0310.7214.0414.7912.867.15
P/S Ratio1.871.762.162.073.571.67
P/B Ratio3.052.522.301.942.151.78
Price/Tangible Book--5.3819.3964.9496.52
Price/FCF9.6322.599.56-1008.4338.15
Price/OCF8.9116.868.85-232.2222.82
PEG Ratio0.400.400.401.111.02-
Enterprise Value Ratios
EV/Revenue2.282.582.412.894.472.56
EV/EBITDA11.5015.5710.7526.9350.6418.40
EV/EBIT24.1246.6823.73---
EV/FCF11.7333.1310.67-1263.3158.56
Profitability & Returns
Return on Equity (ROE)16.16%-4.18%4.72%-13.74%-15.37%-11.04%
Return on Assets (ROA)3.82%1.94%3.72%-2.10%-2.86%-2.12%
Return on Invested Capital (ROIC)7.68%4.77%8.51%-4.58%-6.04%-4.26%
Return on Capital Employed (ROCE)7.20%3.10%6.50%-3.90%-4.10%-4.10%
Leverage & Solvency Ratios
Debt/Equity1.161.460.620.850.801.02
Debt/EBITDA3.526.142.618.2615.066.87
Debt/FCF3.6713.062.60-375.6521.88
Liquidity Ratios
Current Ratio2.712.723.573.463.682.17
Quick Ratio2.071.922.632.152.611.32
Efficiency Ratios
Asset Turnover0.650.560.580.410.350.45
Inventory Turnover2.441.911.681.481.411.60
Yield & Distribution Ratios
Earnings Yield4.75%-1.72%1.79%-7.30%-5.52%-6.47%
FCF Yield10.39%4.43%10.46%-6.11%0.10%2.62%
Payout Ratio1.48%-8.65%---
Buyback Yield-9.89%-6.18%-11.89%-29.09%-5.28%0.63%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About ANI Pharmaceuticals Financial Ratios

What is ANI Pharmaceuticals's P/E ratio?

ANI Pharmaceuticals's P/E ratio was 23.50 for fiscal 2025 (period ended Dec 31, 2025).

What is ANI Pharmaceuticals's return on equity?

ANI Pharmaceuticals's return on equity (ROE) was 16.2% for fiscal 2025 (period ended Dec 31, 2025). It was -4.2% a year earlier.

What is ANI Pharmaceuticals's debt-to-equity ratio?

ANI Pharmaceuticals's debt-to-equity ratio was 1.16 for fiscal 2025 (period ended Dec 31, 2025). It was 1.46 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition